Is Check Cap Ltd (CHEK) Stock a buy now?
Things have started to change for Check Cap since the NASDAQ compliance re-gain extension. The clinical-stage medical diagnostics company shares are trading with strong momentum. The average trading volume of Check-Cap Ltd. (CHEK) is just over 8 million. As we write this on Jan 5., the trading volume is almost 235 million. Is it a […]
Should you invest in Atlantic American (AAME) Stock anytime soon?
Atlantic American stock in on the move; what does this indicate for the investors. The Atlanta-based insurance holding firm has made a bold move after the recent trading session on Monday. The Atlantic American Corp. (AAME) stock has soared over 11% as we write this on Jan. 5. Moreover, the volume has also increased in the […]
How did Synthetic Biologics, Inc. (NYSE American: SYN) climb during premarket?
Clinical-stage company Synthetic Biologics, Inc. (NYSE American: SYN) develops therapeutics for gastrointestinal diseases. Its lead product candidates include SYN-004 that has completed Phase II clinical studies designed to degrade commonly used intravenous beta-lactam antibiotics that have been in use for years. Recent Performance In the recent session Company’s stock finished up 30.57% to $0.50. During […]
BMO Capital lifts Avery Dennison [AVY] rating to Outperform and price target to $184
BMO Capital took its Avery Dennison [AVY] rating to the equivalent of Outperform from Market Perform, and the price target to $184, in a research note dated 2021-01-05. That figure represents around a 21.16% premium from where the company’s shares closed on Monday. Other analysts also revised their coverage, with JP Morgan’s analysts upgrading the […]
Dentsply Sirona [XRAY] gets its Neutral rating reiterated by HC Wainwright & Co.
HC Wainwright & Co. maintained its Dentsply Sirona [XRAY] rating to the equivalent of Neutral but changed the price target to $55.0 from $49, in a research note dated 2021-01-05. That figure represents around a 2.33% premium from where the company’s shares closed on Monday. Other analysts also revised their coverage, with Barclays’s analysts downgrading […]
Concrete Pumping Holdings [BBCP] Stock Gets an Upgrade from Baird. It’s Now Outperform
Baird took its Concrete Pumping Holdings [BBCP] rating to the equivalent of Outperform from Neutral, and the price target to $5, in a research note dated 2021-01-05. That figure represents around a 29.87% premium from where the company’s shares closed on Monday. Other analysts also revised their coverage, with B. Riley FBR’s analysts upgrading the […]
Canadian Solar [CSIQ] Stock Gets a Downgrade from Goldman Sachs. It’s Now Neutral
Goldman Sachs took its Canadian Solar [CSIQ] rating to the equivalent of Neutral from Buy, and the price target to $48, in a research note dated 2021-01-05. Meanwhile, Cascend Securities had raised its rating on CSIQ to “Buy” from the earlier “Hold”, in a research note produced for clients February 20, 2019. In addition, there […]
Deutsche bank raises Dine Brands Global [DIN]’s rating to Buy and price target to $77
Deutsche bank took its Dine Brands Global [DIN] rating to the equivalent of Buy from Hold, and the price target to $77, in a research note dated 2021-01-05. That figure represents around a 33.75% premium from where the company’s shares closed on Monday. Other analysts also revised their coverage, with MKM Partners’s analysts downgrading the […]
Goldman Sachs lifts Enphase Energy [ENPH] rating to Buy and price target to $232
Goldman Sachs took its Enphase Energy [ENPH] rating to the equivalent of Buy from Neutral, and the price target to $232 from $127, in a research note dated 2021-01-05. That figure represents around a 34.7% premium from where the company’s shares closed on Monday. Other analysts also revised their coverage, with Needham’s analysts reiterating the […]
Huntington Bancshares [HBAN] gets an upgrade to an Overweight from Piper Sandler
Piper Sandler took its Huntington Bancshares [HBAN] rating to the equivalent of Overweight from Neutral, in a research note dated 2021-01-05. Other analysts also revised their coverage, with JP Morgan’s analysts upgrading the shares from “a Neutral” rating to “an Overweight” rating in a research note to investors issued in mid December. Meanwhile, Wedbush had […]
